Journal article : Review
Head-to-head comparisons of the distributional characteristics and measurement properties of the three-level and five-level versions of the EQ-5D-Y: a systematic review
- Abstract:
-
Objective:
This systematic review compared the distributional characteristics and measurement properties of EuroQol's EQ-5D-Y-3L and EQ-5D-Y-5L instruments, using results from published head-to-head comparative studies.
Methods:
The review was reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-COnsensus-based Standards for the selection of health Measurement INstruments (PRISMA-COSMIN) guideline. We searched 8 databases up to February 14, 2024 for studies on the measurement properties and distributional characteristics (missing data, ceiling/ floor effects, consistency, and informativity) of both EQ-5D-Y versions. Measurement quality was assessed in terms of the proportion of tests meeting COSMIN recommended criteria for reliability, validity, and responsiveness.
Results:
Eighteen studies were included. The Y-5L reduced ceiling effects by 0.8-16.5% and had a slightly higher evenness index, indicating greater informativity. Both versions showed sufficient construct validity across patient and general population samples, with the Y-5L slightly outperforming the Y-3L in known-group validity. Both the Y-3L and Y-5L versions showed sufficient test-retest reliability for mobility, pain/discomfort, and worried, sad, or unhappy, and inconsistent reliability for looking after myself and usual activities, indicating similar performance across these dimensions. The Y-5L showed better responsiveness (standardised effect size range=0.03-2.05) than Y-3L (range=0.13-0.94). In proxy-reported data, the Y-5L appears to have slightly lower test-retest reliability than the Y-3L, despite demonstrating better agreement with self-reported data.
Conclusion:
Both EQ-5D-Y versions demonstrated varying psychometric performances across the evaluated populations, with the Y-5L slightly outperforming the Y-3L in responsiveness and proxy-child agreement. The availability of the Y-5L expands the options of health-related quality of life instruments for assessing paediatric populations. Further research is needed to assess its performance across diverse populations and administrative modes.
- Publication status:
- Published
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.2MB, Terms of use)
-
(Supplementary materials, zip, 2.5MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.jval.2025.03.020
Authors
- Publisher:
- Elsevier
- Journal:
- Value in Health More from this journal
- Volume:
- 28
- Issue:
- 10
- Pages:
- 1574 - 1586
- Place of publication:
- United States
- Publication date:
- 2025-04-15
- Acceptance date:
- 2025-03-12
- DOI:
- EISSN:
-
1524-4733
- ISSN:
-
1098-3015
- Pmid:
-
40246069
- Language:
-
English
- Keywords:
- Subtype:
-
Review
- Pubs id:
-
2120182
- Local pid:
-
pubs:2120182
- Deposit date:
-
2025-05-16
- ARK identifier:
Terms of use
- Copyright holder:
- Cheng et al.
- Copyright date:
- 2025
- Rights statement:
- © 2025, International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record